# Tvardi Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Dec 18, 2024

- Company: [Tvardi Therapeutics, Inc.](/companies/tvrd.md) (CIK 1346830)
- Form: SCHEDULE 13D/A
- Filed: 2024-12-18
- Accepted by EDGAR: Dec 18, 2024, 17:10 ET
- Period: not reported
- Accession: 0000950170-24-137983
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1346830/000095017024137983/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1346830/000095017024137983/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1346830/000095017024137983/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Dec 18, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-137983. Last ingested by Listed: Oct 24, 2026, 15:11 ET. No prices; not investment advice.